Study Evaluates Use of Milvexian in Secondary Stroke Prevention
The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.
Source: pharmacytimes.com
Librexia Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Librexia Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Librexia Stroke Today - Breaking & Trending Today
Milvexian granted fast track designation for prevention of thrombotic events
Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals announced all three prospective antithrombotic indications for milvexian have received fast track designation from the FDA. The designation covers all three phase 3 Librexia development studies of the investigational oral factor XIa inhibitor: Librexia Stroke, Librexia ACS and Librexia AF. According to a company press release, the
Source: healio.com